Skip to main navigation
  • LogicBio Therapeutics, Inc.

Investors

  • About
  • GeneRide
  • Pipeline
  • Patients & Families
    • Yusuf's Story
    • Khadija's Story
    • Melissa's Story
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • IR Search
  • Careers
  • Contact

Investors Menu

  • Overview
  • Press Releases
  • Events and Presentations
    • Event Calendar
    • Presentations
  • Stock Information
    • Stock Chart & Quote
    • Historic Price Lookup
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • SEC Filings
  • Analyst Coverage
  • Investor FAQs
  • Email Alerts
  • Contact IR
  • IR Search

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Jan 4, 2021
Document Date
Jan 1, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
LogicBio Therapeutics, Inc.
Issuer
LogicBio Therapeutics, Inc.
Filer
Kay Mark A

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
© 2021 LogicBio Therapeutics, Inc.
  • Privacy Policy
  • Contact